Veru Inc. (VERU) stock
VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
$2.11−0.20 (-8.66%)
Close on Nov 19, 2026Market cap $35.98MP/E –Yield –
Veru net income
Net income is the profit left for shareholders after every expense, interest and tax.
Veru's net income for the twelve months ending Jun 30, 2026 was -$13.61M. For fiscal 2025 it was -$22.73M. The highest annual figure on record is $15.30M in fiscal 2012.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$22.73M | – |
| FY2024 | Sep 30, 2024 | -$37.80M | – |
| FY2023 | Sep 30, 2023 | -$93.15M | – |
| FY2022 | Sep 30, 2022 | -$84.04M | -1236.5% |
| FY2021 | Sep 30, 2021 | $7.39M | – |
| FY2020 | Sep 30, 2020 | -$18.97M | – |
| FY2019 | Sep 30, 2019 | -$12.02M | – |
| FY2018 | Sep 30, 2018 | -$23.94M | – |
| FY2017 | Sep 30, 2017 | -$6.61M | -2018.1% |
| FY2016 | Sep 30, 2016 | $344.73K | -92.1% |
| FY2015 | Sep 30, 2015 | $4.35M | +78.6% |
| FY2014 | Sep 30, 2014 | $2.43M | -83.0% |
| FY2013 | Sep 30, 2013 | $14.34M | -6.3% |
| FY2012 | Sep 30, 2012 | $15.30M | +183.4% |
| FY2011 | Sep 30, 2011 | $5.40M | -19.9% |
| FY2010 | Sep 30, 2010 | $6.74M | +3.1% |
| FY2009 | Sep 30, 2009 | $6.54M | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | -$6.99M | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | -$2.74M | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$5.33M | – |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $1.45M | – |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -$7.33M | – |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | -$7.90M | – |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | -$8.95M | – |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | -$8.53M | – |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | -$10.97M | – |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -$10.03M | – |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | -$8.28M | – |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | -$8.13M | – |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | -$12.52M | – |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | -$33.79M | – |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | -$38.71M | – |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | -$41.29M | – |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | -$22.20M | – |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | -$14.18M | – |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | -$6.38M | -137.0% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -$4.29M | – |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | -$2.69M | – |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | -$2.85M | – |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $17.23M | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | -$11.83M | – |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | -$3.03M | – |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | -$810.51K | – |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | -$3.31M | – |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | -$3.06M | – |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | -$2.77M | – |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | -$4.03M | – |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | -$2.15M | – |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | -$7.92M | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | -$7.93M | – |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | -$3.83M | – |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | -$4.26M | – |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | -$2.68M | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -$789.89K | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | -$1.78M | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | -$1.37M | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | -$1.75M | – |
See a number that looks wrong?